Clinical trials: Cerebrospinal Fluid
Healthy
Measurement of Insulin Levels in Cerebral Spinal Fluid (CSF) of Healthy Adults After a Single Intranasal Dose
The purpose of this study is to find out whether insulin, a drug approved by the FDA for the treatment of diabetes mellitus, reaches the brain and spinal cord when delivered as a nasal spray (intranasally).
- Trial name
- INI-CSF (NCT05866367)
- Testing
- Low dose Regular Insulin, High dose Regular insulin
- Where
- United States
- Volunteers
- 2 people, healthy volunteers welcome
- Sponsor
- HealthPartners Institute